Hints and tips:
Related Special Reports
...Chief executives at AbbVie, Eli Lilly, and Johnson & Johnson all earned more than Soriot in 2023....
...The Danish drugmaker has no plans to cut the price of the blockbuster weight-loss drug, despite new competition from US rival Eli Lilly, which plans a list price for its Zepbound drug that is 20 per cent...
...But the human rights element of the lawsuit brought by PAF against AbbVie is novel because it considers the overall effect of high prices on healthcare and society, even for those who did not directly access...
...“Misaligned incentives across the US healthcare system have led to meaningful delays and barriers to biosimilar adoption, resulting in significant missed opportunities for healthcare savings,” the Swiss...
...South Korea on Friday raised its healthcare alert to the highest level as the widening strike by trainee doctors adds strain on the country’s medical system....
...South Korea’s healthcare system was placed on its highest state of alert last week after thousands of trainee doctors resigned in protest against government plans to increase medical school admissions....
...The answer lies in shorter-term practical wins the public can get behind, plus medium to longer-term plans for overdue change. More investment is unavoidable....
...The US federal government is the single largest payer for healthcare in America....
...The company has set out to develop the largest injectibles business in the market, taking on competitors such as AbbVie and Merz....
...The UK’s plan — which applies to England, but stresses the need to “work collaboratively” with the devolved administrations in Scotland, Wales and Northern Ireland — includes identifying parts of the healthcare...
...Tuesday’s break-up completes a plan launched in 2021 to separate the industrial titan’s energy, aviation and healthcare units. GE’s influence and its valuation have declined for more than a decade....
...US healthcare stocks featured heavily among Wall Street’s worst performers after the White House’s payment rate to private Medicare plans came in below market expectations....
...The S&P 500 dropped 0.7 per cent. Tuesday’s break-up completes a plan launched in 2021 to separate the industrial titan’s energy, aviation and healthcare units....
...INA’s Porwanto said the rating opened up the possibility of obtaining financing from the offshore market, although there was no imminent fundraising plan....
...They put a lot of strain on healthcare systems,” she told the Financial Times....
...“Children’s healthcare should always be led by evidence and children’s welfare, free from culture wars. Clinicians and parents alike want the best for children at this crucial developmental stage....
...Handler described the sale as “a gift to myself and my family” and stressed he had no plans to sell any more of his stock, which is still worth about $800mn....
...Healthcare is expected to become a key battleground at the general election, expected later this year....
...“Labour’s plans will cost the taxpayer a lot more as very large profits are being made from NHS care by private companies,” he said....
...The document, the first comprehensive “silver economy” roadmap, also calls for investment in financial products and pensions to meet the needs of the elderly, along with increased access to healthcare, education...
...In his annual letter to shareholders, the head of the largest US bank by assets said JPMorgan had plans for interest rates going above 8 per cent and as low as 2 per cent....
...Last year, the independent public spending watchdog warned that the UK government was failing to co-ordinate and track the progress of its £1.7bn plan to improve the quality of England’s social care over...
...In one sign that Amazon is expanding beyond the retail space, however, health plan provider Blue Shield of California announced in August that Amazon Pharmacy would start dispensing some prescription medications...
...The San Diego-based biotech is close to completing a pre-IPO financing round in which it will raise between $75mn and $100mn from a group of blue-chip healthcare investors, according to three people familiar...
International Edition